We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Build a Balanced Portfolio with 4 Top Value Stocks as Markets Surge
The U.S. stock market continued its upward momentum on Monday, reaching fresh highs amid optimism spurred by the recent presidential election and favorable economic signals. Wall Street's major indexes closed at new highs, building on Friday's record-breaking performance. Investors appear increasingly positive about the prospects of pro-growth fiscal policies under President-elect Donald Trump, while the Federal Reserve's recent interest rate cut has also bolstered market sentiment.
The S&P 500 rose 0.10% to close at 6,001.35, while the Nasdaq Composite jumped 0.06%, ending the session at 19,298.76. Leading the gains, the Dow Jones Industrial Average climbed 0.69% to reach 44,293.13. Bitcoin also hit unprecedented levels, marking a significant milestone in the cryptocurrency market.
As major indexes hit record highs and digital assets reach unprecedented levels, investors might consider balancing their portfolios with value stocks. Typically trading below their intrinsic value, these stocks offer a margin of safety during market fluctuations.
When evaluating value stocks, one of the most effective valuation metrics is the Price to Cash Flow (P/CF) ratio. This metric measures the market price of a stock relative to the cash flow the company generates on a per-share basis. A lower P/CF ratio indicates that the stock is trading at a better value, offering strong cash generation potential relative to its price. Here are four companies — StoneCo Ltd., Skechers U.S.A., Inc., Pfizer Inc. and General Motors Co. — that boast low P/CF ratios, making them strong contenders for value-seeking investors.
Price to Cash Flow Reveals Financial Health
Questions may arise as to why we are considering the P/CF valuation metric when the most widely used metric is Price/Earnings (or P/E). Well, what makes P/CF stand out is that operating cash flow adds back non-cash charges such as depreciation and amortization to net income, truly reflecting the financial health of a company.
Analysts caution that a company’s earnings are subject to accounting estimates and management manipulation. However, cash flow is reliable. It is net cash flow that reveals how much money a company is actually generating and how effectively management is putting the same to use.
A positive cash flow indicates an increase in the company’s liquid assets. This gives the company the means to settle debt, shell out for its expenses, reinvest in its business, endure downturns, and finally pay back its shareholders. Then again, a negative cash flow implies a decline in the company’s liquidity, which in turn lowers its flexibility to support these moves.
What’s the Best Value Investing Strategy?
An investment decision solely based on the P/CF metric may not fetch the desired results. To identify stocks that are trading at a discount, you should expand your search criteria and also consider the price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio. Adding a favorable Zacks Rank and a Value Score of A or B to your search criteria should lead to even better results as these eliminate the chance of falling into a value trap.
Here are four of the nine value stocks that qualified the screening:
StoneCo is a leading provider of financial technology and software solutions that facilitate merchants to conduct commerce seamlessly. This Zacks Rank #1 company has a trailing four-quarter earnings surprise of 5.4%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for StoneCo’s current financial year sales and earnings per share (EPS) suggests growth of 0.2% and 24.7%, respectively, from the year-ago period. STNE has a Value Score of B. Shares of STNE have decreased 4.4% in the past year.
Skechers designs, develops and markets a diverse range of lifestyle and performance footwear, apparel, and accessories. This Zacks Rank #2 company has a trailing four-quarter earnings surprise of 8.8%, on average.
The Zacks Consensus Estimate for Skechers’ current financial year sales and EPS suggests growth of 12.2% and 20.6%, respectively, from the year-ago period. Skechers has a Value Score of A. Shares of SKX have rallied 23.5% in the past year.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Pfizer, which develops, manufactures, markets, distributes, and sells biopharmaceutical products, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 74.5%, on average.
The Zacks Consensus Estimate for Pfizer’s current financial year sales and EPS suggests growth of 7.7% and 56.5%, respectively, from the year-ago period. Pfizer has a Value Score of A. Shares of PFE have declined 9.4% in the past year.
General Motors, which designs, builds, and sells cars, trucks, crossovers, and automobile parts globally, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 17.5%, on average.
The Zacks Consensus Estimate for General Motors’ current financial year sales and EPS suggests growth of 4.8% and 34%, respectively, from the year-ago period. General Motors has a Value Score of A. Shares of GM have advanced 114.4% in the past year.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights include StoneCo, Skechers, Pfizer and General Motors
For Immediate Release
Chicago, IL – November 13, 2024 – Stocks in this week’s article are StoneCo Ltd. (STNE - Free Report) , Skechers U.S.A., Inc. (SKX - Free Report) , Pfizer Inc. (PFE - Free Report) and General Motors Co. (GM - Free Report) .
Build a Balanced Portfolio with 4 Top Value Stocks as Markets Surge
The U.S. stock market continued its upward momentum on Monday, reaching fresh highs amid optimism spurred by the recent presidential election and favorable economic signals. Wall Street's major indexes closed at new highs, building on Friday's record-breaking performance. Investors appear increasingly positive about the prospects of pro-growth fiscal policies under President-elect Donald Trump, while the Federal Reserve's recent interest rate cut has also bolstered market sentiment.
The S&P 500 rose 0.10% to close at 6,001.35, while the Nasdaq Composite jumped 0.06%, ending the session at 19,298.76. Leading the gains, the Dow Jones Industrial Average climbed 0.69% to reach 44,293.13. Bitcoin also hit unprecedented levels, marking a significant milestone in the cryptocurrency market.
As major indexes hit record highs and digital assets reach unprecedented levels, investors might consider balancing their portfolios with value stocks. Typically trading below their intrinsic value, these stocks offer a margin of safety during market fluctuations.
When evaluating value stocks, one of the most effective valuation metrics is the Price to Cash Flow (P/CF) ratio. This metric measures the market price of a stock relative to the cash flow the company generates on a per-share basis. A lower P/CF ratio indicates that the stock is trading at a better value, offering strong cash generation potential relative to its price. Here are four companies — StoneCo Ltd., Skechers U.S.A., Inc., Pfizer Inc. and General Motors Co. — that boast low P/CF ratios, making them strong contenders for value-seeking investors.
Price to Cash Flow Reveals Financial Health
Questions may arise as to why we are considering the P/CF valuation metric when the most widely used metric is Price/Earnings (or P/E). Well, what makes P/CF stand out is that operating cash flow adds back non-cash charges such as depreciation and amortization to net income, truly reflecting the financial health of a company.
Analysts caution that a company’s earnings are subject to accounting estimates and management manipulation. However, cash flow is reliable. It is net cash flow that reveals how much money a company is actually generating and how effectively management is putting the same to use.
A positive cash flow indicates an increase in the company’s liquid assets. This gives the company the means to settle debt, shell out for its expenses, reinvest in its business, endure downturns, and finally pay back its shareholders. Then again, a negative cash flow implies a decline in the company’s liquidity, which in turn lowers its flexibility to support these moves.
What’s the Best Value Investing Strategy?
An investment decision solely based on the P/CF metric may not fetch the desired results. To identify stocks that are trading at a discount, you should expand your search criteria and also consider the price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio. Adding a favorable Zacks Rank and a Value Score of A or B to your search criteria should lead to even better results as these eliminate the chance of falling into a value trap.
Here are four of the nine value stocks that qualified the screening:
StoneCo is a leading provider of financial technology and software solutions that facilitate merchants to conduct commerce seamlessly. This Zacks Rank #1 company has a trailing four-quarter earnings surprise of 5.4%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for StoneCo’s current financial year sales and earnings per share (EPS) suggests growth of 0.2% and 24.7%, respectively, from the year-ago period. STNE has a Value Score of B. Shares of STNE have decreased 4.4% in the past year.
Skechers designs, develops and markets a diverse range of lifestyle and performance footwear, apparel, and accessories. This Zacks Rank #2 company has a trailing four-quarter earnings surprise of 8.8%, on average.
The Zacks Consensus Estimate for Skechers’ current financial year sales and EPS suggests growth of 12.2% and 20.6%, respectively, from the year-ago period. Skechers has a Value Score of A. Shares of SKX have rallied 23.5% in the past year.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Pfizer, which develops, manufactures, markets, distributes, and sells biopharmaceutical products, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 74.5%, on average.
The Zacks Consensus Estimate for Pfizer’s current financial year sales and EPS suggests growth of 7.7% and 56.5%, respectively, from the year-ago period. Pfizer has a Value Score of A. Shares of PFE have declined 9.4% in the past year.
General Motors, which designs, builds, and sells cars, trucks, crossovers, and automobile parts globally, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 17.5%, on average.
The Zacks Consensus Estimate for General Motors’ current financial year sales and EPS suggests growth of 4.8% and 34%, respectively, from the year-ago period. General Motors has a Value Score of A. Shares of GM have advanced 114.4% in the past year.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2369188/build-a-balanced-portfolio-with-4-top-value-stocks-as-markets-surge
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.